MiNK Therapeutics, Inc. (INKT)
11.84
+0.39
(+3.41%)
USD |
NASDAQ |
Sep 09, 16:00
11.84
0.00 (0.00%)
After-Hours: 16:48
MiNK Therapeutics Total Assets (Quarterly) : 9.615M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.615M |
| March 31, 2026 | 10.38M |
| December 31, 2025 | 14.24M |
| September 30, 2025 | 14.96M |
| June 30, 2025 | 2.484M |
| March 31, 2025 | 4.267M |
| December 31, 2024 | 5.721M |
| September 30, 2024 | 7.375M |
| June 30, 2024 | 10.32M |
| March 31, 2024 | 6.894M |
| December 31, 2023 | 4.552M |
| Date | Value |
|---|---|
| September 30, 2023 | 7.462M |
| June 30, 2023 | 12.11M |
| March 31, 2023 | 16.59M |
| December 31, 2022 | 21.47M |
| September 30, 2022 | 25.26M |
| June 30, 2022 | 31.12M |
| March 31, 2022 | 36.14M |
| December 31, 2021 | 40.24M |
| September 30, 2021 | 4.077M |
| June 30, 2021 | 4.753M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 23.64M |
| Shareholders Equity (Quarterly) | -14.03M |
| Current Ratio | 1.228 |
| Net Debt Paydown Yield | 1.72% |